Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease

被引:58
作者
Kanaya, AM
Herrington, D
Vittinghoff, E
Lin, F
Bittner, V
Cauley, JA
Hulley, S
Barrett-Connor, E
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] Univ Pittsburgh, Pittsburgh, PA USA
[5] Univ Calif San Diego, La Jolla, CA 92093 USA
关键词
D O I
10.7326/0003-4819-142-10-200505170-00006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Type 2 diabetes increases risk for cardiovascular disease. Persons with impaired fasting glucose levels may also have increased risk. Objective: To evaluate the association between glucose status and cardiovascular outcomes and the effect of lowering the fasting glucose level criterion for impaired fasting glucose from a lower limit of 6.1 mmol/L (110 mg/dL) to 5.6 mmol/L (100 mg/dL). Design: Prospective cohort study. Setting: 20 U.S. clinical centers. Patients: 2763 postmenopausal women with established coronary heart disease (CHD) who were followed for 6.8 years. Measurements: Any CHD event (nonfatal myocardial infarction or CHD death), stroke or transient ischemic attack (TIA), congestive heart failure (CHF) hospitalization, and any cardiovascular event. Results: During follow-up, 583 women had a CHD event, 329 women had a stroke or TIA, and 348 women were hospitalized for CHF. Women with diabetes were at an approximately 75% increased risk for each outcome compared with normoglycemic women. The 218 women with impaired fasting glucose according to the 1997 definition (fasting glucose level, 6.1 to 6.9 mmol/L [110 to 125 mg/dL]) had increased risk for any CHID event (hazard ratio, 1.37 [95% CI, 1.08 to 1.74]), while the 698 women with impaired fasting glucose according to the 2003 definition (fasting glucose level, 5.6 to 6.9 mmol/L [100 to 125 mg/dL]) were not at increased risk (hazard ratio, 1.09 [CI, 0.90 to 1.34]). Most of the women (n = 480) with fasting glucose levels between 5.6 mmol/L (100 mg/dL) and 6.0 mmol/L (109 mg/dL) had no increased risk for CHD (hazard ratio, 0.90 [CI, 0.73 to 1.12]). Women with impaired fasting glucose according to either definition were not at increased risk for stroke or TIA or CHF. Limitations: These findings may not be generalizable to men or women without existing heart disease. Conclusions: Among postmenopausal women with coronary artery disease, the 2003 definition for impaired fasting glucose was not associated with increased risk for new CHID, stroke or TIA, or CHF.
引用
收藏
页码:813 / 820
页数:8
相关论文
共 28 条
[1]  
[Anonymous], 2003, MMWR-MORBID MORTAL W, V52, P833
[2]   High fasting glucose levels as a predictor of worse clinical outcome in patients with coronary artery disease: Results from the Bezafibrate Infarction Prevention (BIP) study [J].
Arcavi, L ;
Behar, S ;
Caspi, A ;
Reshef, N ;
Boyko, V ;
Knobler, H .
AMERICAN HEART JOURNAL, 2004, 147 (02) :239-245
[3]   DIABETIC CARDIOMYOPATHY - A UNIQUE ENTITY OR A COMPLICATION OF CORONARY-ARTERY DISEASE [J].
BELL, DSH .
DIABETES CARE, 1995, 18 (05) :708-714
[4]  
Borch-Johnsen K, 1998, BMJ-BRIT MED J, V317, P371
[5]  
Borch-Johnsen K, 1999, LANCET, V354, P617
[6]   Glucose tolerance and cardiovascular mortality -: Comparison of fasting and 2-hour diagnostic criteria [J].
Borch-Johnsen, K ;
Neil, A ;
Balkau, B ;
Larsen, S ;
Nissinen, A ;
Pekkanen, J ;
Tuomilehto, J ;
Jousilahti, P ;
Lindstrom, J ;
Pyörälä, M ;
Pyörälä, K ;
Eschwege, E ;
Gallus, G ;
Garancini, MP ;
Bouter, LM ;
Dekker, JM ;
Heine, RJ ;
Nijpels, HG ;
Stehouwer, CDA ;
Feskens, EJM ;
Kromhout, D ;
Peltonen, M ;
Pajak, A ;
Eriksson, J ;
Qiao, Q .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (03) :397-405
[7]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[8]   Lowering the criterion for impaired fasting glucose will not provide clinical benefit [J].
Davidson, MB ;
Landsman, PB ;
Alexander, CM .
DIABETES CARE, 2003, 26 (12) :3329-3330
[9]   Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population - The Hoorn study [J].
de Vegt, F ;
Dekker, JM ;
Jager, A ;
Hienkens, E ;
Kostense, PJ ;
Stehouwer, CDA ;
Nijpels, G ;
Bouter, LM ;
Heine, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (16) :2109-2113
[10]   Impact of diabetes on cardiac structure and function - The strong heart study [J].
Devereux, RB ;
Roman, MJ ;
Paranicas, M ;
O'Grady, MJ ;
Lee, ET ;
Welty, TK ;
Fabsitz, RR ;
Robbins, D ;
Rhoades, ER ;
Howard, BV .
CIRCULATION, 2000, 101 (19) :2271-2276